Clinical Trials Logo

Filter by:
NCT ID: NCT05395429 Recruiting - Thyroid Cancer Clinical Trials

Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients

Start date: March 25, 2022
Phase:
Study type: Observational

The purpose of this trail is to evaluate the performance of Genetron TERT/BRAF PCR Kit in Thyriod Cancer patients using real-time PCR method.

NCT ID: NCT05395416 Recruiting - Clinical trials for Chronic HCV Infection

Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C

Start date: June 21, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The safety, tolerability and antiviral activity of Antaitavir Hasophate in Combination With Yiqibuvir in treatment-naive and treatment-experienced patients with chronic hepatitis C virus (HCV) infection

NCT ID: NCT05394727 Recruiting - Clinical trials for Gestational Diabetes

Application of Needle-free Injection of Insulin in Patients With Gestational Diabetes Mellitus

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This study is about the application of needle-free injection device in GDM patients in order to observe the variation of blood glucose and patients' experience compared to the traditional insulin pen injection. To provide evidence for the application of needle-free syringe injection in GDM patients.

NCT ID: NCT05394415 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC

LATE
Start date: May 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a single institution and single-arm phase I/II study to assess the feasibility and efficacy of tislelizumab plus chemoradiation for conversion therapy of patients with locally nonresectable ESCC.

NCT ID: NCT05394402 Recruiting - Postsurgical Pain Clinical Trials

A Trial of SHR0410 Injection in Postsurgical Pain Management

Start date: August 9, 2022
Phase: Phase 2
Study type: Interventional

The study is being conducted to evaluate the efficacy, safety of SHR0410 Injection and to explore the reasonable of SHR0410 Injection for Pain Management after Orthopaedic Surgery.

NCT ID: NCT05394285 Recruiting - Breast Cancer Clinical Trials

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Chemotherapy in Advanced Breast Cancer

Start date: August 19, 2022
Phase: Phase 2
Study type: Interventional

This study now plans to explore the efficacy and safety of hetrombopag in chemotherapy-induced thrombocytopenia in advanced breast cancer, so as to further guide the clinical application of hetrombopag in chemotherapy-induced platelets.

NCT ID: NCT05394246 Recruiting - Liver Cancer Clinical Trials

Fluorescent-labeled IgG for Liver Tumor Detection

Start date: May 20, 2022
Phase: N/A
Study type: Interventional

This study is to evaluate whether intraoperative fluorescence imaging using fluorescent-labeled IgG probe (FluoAB) can help distinguish the tumor and the liver cirrhosis (or the liver parenchyma). The main purposes of this study include: - To validate the safety and effectiveness of using FluoAB in hepatic surgery. - To raise the surgical precision with guidance by FluoAB fluorescence imaging.

NCT ID: NCT05394116 Recruiting - Clinical trials for Fibrodysplasia Ossificans Progressiva

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

OPTIMA
Start date: November 21, 2022
Phase: Phase 3
Study type: Interventional

This study is researching an experimental drug called garetosmab. The study is focused on adult patients with fibrodysplasia ossificans progressiva (FOP). The aim of the study is to see how safe and effective the study drug is in patients with FOP. The study is looking at several other research questions, including: - What side effects may happen from receiving the study drug - How much study drug is in your blood at different times - Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

NCT ID: NCT05393986 Recruiting - Pancreatic Cancer Clinical Trials

Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors

Start date: August 4, 2022
Phase: Phase 1
Study type: Interventional

An Open-Label, Single-Arm, Dose-Exploration Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of CT048 in Subjects with Advanced Solid Tumors

NCT ID: NCT05393453 Recruiting - Clinical trials for Acute-On-Chronic Liver Failure

Prognosis of Patients With Acute-on-chronic Liver Failure

Start date: June 1, 2022
Phase:
Study type: Observational

Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis. This study mainly prospectively analyze the clinical data of patients with chronic liver disease related acute liver failure admitted to the department of infectious diseases, Xiangya Hospital of Central South University, to analyze the prognosis of patients with chronic liver disease related acute on-chronic liver failure in Central South China. No additional interventions other than routine treatment will be added.